We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac Implants Could Potentially Be Powered Wirelessly

By HospiMedica International staff writers
Posted on 11 Oct 2012
Remotely powering a millimeter-sized cardiac device could dramatically alter the scale of medical devices implanted inside the human body.

Researchers a Stanford University (CA, USA) analyzed wireless power transfer between a source and a weakly coupled implant on the heart, and succeeded in showing that mid-field wireless powering achieves much higher power transfer efficiency than traditional inductively coupled systems. More...
The researchers then demonstrated wireless power transfer to a millimeter-sized device implanted five centimeters inside the chest, on the surface of the heart, a depth once thought out of reach for wireless power transmission.

The device works by a combination of inductive and radiative electromagnetic transfer using radio waves that are received by a coiled antenna inside the body. The radio waves produce an electrical current in the coil that is sufficient to operate a small device. The amount of power available is indirectly related to the frequency of the transmitted radio waves, and the size of the receiving antenna. To deliver a certain level of power, lower frequency waves require bigger coils; but higher frequency waves can work with smaller coils.

Existing mathematical models, however, hold that high frequency radio waves do not penetrate far enough into human tissue, necessitating the use of low-frequency transmitters and large antennas that are too large to be practical for implantable devices. But according to the researchers, the models are wrong - although human tissues dissipate electric fields quickly, radio waves can travel as alternating waves of electric and magnetic fields. Using revised models, the researchers found that the maximum power transfer through human tissue occurs at about 1.7 billion cycles per second, allowing them to increase power transfer by about 10 times over earlier devices.

The discovery meant that the team could shrink the receive antenna by a factor of 10 as well, to a scale that makes wireless implantable devices feasible. At the optimal frequency, a millimeter-radius coil is capable of harvesting more than 50 microwatts of power, well in excess of the needs of a pacemaker. The researchers also designed an innovative transmit antenna structure that delivers power efficiently, regardless of orientation of the antennas, precisely focusing the radio waves at the point inside the body where the device rests, thus increasing the electric field where it is most needed, but canceling it elsewhere. The study was published online on August 13, 2012, in Applied Physics Letters.

“To achieve greater power efficiency, it is actually advantageous that human tissue is a very poor electrical conductor. If it were a good conductor, it would absorb energy, create heating and prevent sufficient power from reaching the implant,” concluded senior author Ada Poon, PhD, and colleagues of the department of electrical engineering. “With proper system design, power sufficient to operate typical cardiac implants can be received by millimeter-sized coils.”

The researchers added that the research is a major step toward a future in which all implants are driven wirelessly. Beyond the heart, they believe that devices that could benefit from wireless power transfer might include pillcams that travel the digestive tract, permanent pacemakers, and precision brain stimulators. In fact, the devices could potentially be used for virtually any medical applications for which device size and power matter.

Related Links:
Stanford University



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.